Consolidated Statements of Cash Flows - USD ($) $ in Millions		3 Months Ended				12 Months Ended
		Mar. 31, 2020		Mar. 31, 2019		Dec. 31, 2019		Mar. 31, 2020		Dec. 31, 2019		Dec. 31, 2018
Cash Flows from Operating Activities
Net loss		$ (171.9)		$ (33.5)
Loss from discontinued operations, net of tax		(4.7)		(9.5)
Loss from continuing operations, net of tax		(167.2)		(24.0)
Adjustments to reconcile net loss from continuing operations to net cash used by operating activities:
Depreciation		16.3		20.6
Amortization		6.0		6.6
Provision for doubtful accounts		29.7		29.9
Provision for obsolescence		18.6		6.7
Share-based compensation		16.9		(0.5)
Foreign exchange losses (gains)		27.6		(19.2)
Deferred income taxes		8.0		8.2
Impairment loss on assets		0.7		0.0
Gain on sale of business / assets		0.0		(10.3)
Other		10.3		1.7
Changes in assets and liabilities:
Accounts receivable		(18.3)		(24.3)
Inventories		(32.8)		4.8
Prepaid expenses and other		1.0		38.4
Accounts payable and accrued liabilities		(174.0)		(164.2)
Income and other taxes		(24.2)		(12.0)
Noncurrent assets and liabilities		(12.7)		(5.1)
Net cash used by operating activities of continuing operations		(294.1)		(142.7)
Cash Flows from Investing Activities
Capital expenditures		(7.3)		(21.2)
Disposal of assets		2.4		0.4
Net proceeds from sale of business / assets		0.0		46.4
Net cash provided (used) by investing activities of continuing operations		(4.9)		25.6
Cash Flows from Financing Activities
Payments of Dividends		(8.6)		0.0
Debt, net (maturities of three months or less)		1.8		27.2
Settlement of stock options		(25.8)		0.0
Other financing activities		(0.6)		(9.2)
Net cash provided (used) by financing activities of continuing operations		(33.2)		18.0
Net cash used by operating activities of discontinued operations		(6.7)		0.0
Net cash used by discontinued operations		(6.7)		0.0
Effect of exchange rate changes on cash and cash equivalents, and restricted cash		(20.8)		(6.3)
Net decrease in cash and cash equivalents, and restricted cash		(359.7)		(105.4)
Cash and cash equivalents, and restricted cash at beginning of year	[1]	661.1		536.4		$ 536.4
Cash and cash equivalents, and restricted cash at end of period		301.4	[2]	431.0	[2]	661.1	[1]
Cash and cash equivalents, classified as held for sale												$ 3.7
Cash and cash equivalents								$ 294.0		$ 650.6
Restricted cash								7.4		2.9
Long-term restricted cash	[3]							0.0		7.6
Cash and cash equivalents, and restricted cash at end of period per the statement of cash flows		$ 301.4	[2]	$ 431.0	[2]	$ 536.4	[1]	$ 301.4	[2]	$ 661.1	[1]	$ 536.4	[1]

[1] ⁽¹⁾The balance at the beginning of the three month period ended March 31, 2019 includes cash and cash equivalents of $3.7 classified as Held for sale assets in our Consolidated Balance Sheets.

[2] The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Consolidated Balance Sheet that sum to the total of the same such amounts shown in the Consolidated Statement of Cash Flows for the three month period ended March 31, 2019. March 31, 2020December 31, 2019Cash and cash equivalents$294.0  $650.6  Restricted cash7.4  2.9   Long-term restricted cash⁽¹⁾ —  7.6  Cash and cash equivalents, and restricted cash at end of period per the statement of cash flows$301.4  $661.1   ⁽¹⁾ Long-term restricted cash is presented in other assets in our Consolidated Balance Sheets. The balance of $7.6 as of December 31, 2019 resulting from the sale of Avon Manufacturing (Guangzhou), Ltd has been reclassified to short term restricted cash in the three month period ended March 31, 2020.

[3] Long-term restricted cash is presented in other assets in our Consolidated Balance Sheets. The balance of $7.6 as of December 31, 2019 resulting from the sale of Avon Manufacturing (Guangzhou), Ltd has been reclassified to short term restricted cash in the three month period ended March 31, 2020.